Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Clinical Epidemiology|August 3, 2019
A systematic review of the international prevalence of <i>BRCA</i> mutation in breast cancerNigel Armstrong, Steve Ryder, Carol Forbes, et al.Journal of Medical Economics|May 10, 2021
Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in SwedenCarlos Acosta, Mattia Gianinazzi, Thibaut Dort, et al.Future Oncology (London, England)|December 2, 2020
DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic reviewNigel Armstrong, Ruben Gw Quek, Steve Ryder, et al.Pharmacoeconomics|April 6, 2019
A Systematic Review of Direct Cardiovascular Event Costs: An International PerspectiveSteve Ryder, Kathleen Fox, Pratik Rane, et al.Health Technology Assessment (Winchester, England)|March 25, 2014
Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysisPenny Whiting, Maiwenn Al, Laura Burgers, et al.Health Technology Assessment (Winchester, England)|November 17, 2015
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysisMarie Westwood, Bram Ramaekers, Penny Whiting, et al.Health Technology Assessment (Winchester, England)|July 29, 2015
Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysisPenny Whiting, Maiwenn Al, Marie Westwood, et al.Urology|May 24, 2021
SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic ReviewNigel Armstrong, Amit Bahl, Michael Pinkawa, et al.Health Technology Assessment (Winchester, England)|March 3, 2016
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluationRob Riemsma, Isaac Corro Ramos, Richard Birnie, et al.Pharmacoeconomics|August 29, 2015
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from CelgeneHedwig M Blommestein, Nigel Armstrong, Steve Ryder, et al.Pageof 3